The Effect of Lubiprostone, a Chloride Channel Activator, on Colonic Sensorimotor Functions in Healthy Subjects. A Phase IV, Placebo-Controlled, Parallel Group Study.
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Pharmacodynamics
- 24 Feb 2012 Actual end date changed from Mar 2009 to Jul 2009as reported by ClinicalTrials.gov.
- 24 Feb 2012 Actual initiation date changed from Apr 2007 to Sep 2007 as reported by ClinicalTrials.gov.
- 08 Feb 2012 Additional lead trial centres identified as reported by ClinicalTrials.gov.